Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease

被引：5
|
作者：
Katsiki, Niki [2 ]
Elisaf, Moses [1 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Propedeut Dept Internal Med 1, GR-54006 Thessaloniki, Greece
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2011年 / 27卷 / 08期
关键词：
Cardiovascular risk; Chronic kidney disease; Metabolic syndrome; Multifactorial treatment; Renal function; Statin; Uric acid; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; PERIPHERAL ARTERIAL-DISEASE; TYPE-2; DIABETES-MELLITUS; ALL-CAUSE MORTALITY; GREEK ATORVASTATIN; SUBGROUP ANALYSIS; EVALUATION GREACE; VASCULAR-DISEASE;
D O I：
10.1185/03007995.2011.596410
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1669 / 1672
页数：4
相关论文
共 50 条
  • [1] Metabolic Syndrome increases cardiovascular and renal risk in patients with chronic kidney disease
    Aranda, P.
    Aranda, F. J.
    Esteban, A.
    Frutos, M. A.
    JOURNAL OF HYPERTENSION, 2007, 25 : S76 - S76
  • [2] Frequency of Cardiovascular Risk Factors and Metabolic Syndrome in Patients with Chronic Kidney Disease
    Sagun, Gul
    Kantarci, Gulcin
    Mesci, Banu
    Gungor, Sinem
    Turkoglu, Funda
    Yorulmaz, Elif
    Oguz, Aytekin
    CLINICAL MEDICINE & RESEARCH, 2010, 8 (3-4) : 135 - 141
  • [3] CARDIOVASCULAR RISK FACTORS AND THE RELATIONSHIP WITH METABOLIC SYNDROME AND CHRONIC KIDNEY DISEASE
    Caldararu, Carmen D.
    Gliga, Mirela L.
    Tarta, Ionut D.
    Szanto, Annamaria
    Carlan, Otilia
    Dogaru, Grigore A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 133 - 134
  • [4] Multifactorial intervention decreases cardiovascular disease in patients with metabolic syndrome
    Xue, S. H. U. R. E. N.
    EUROPEAN HEART JOURNAL, 2006, 27 : 260 - 260
  • [5] CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC RENAL FAILURE AND METABOLIC SYNDROME
    Bozek, T.
    Peros, K.
    Prkacin, I.
    Jankovic, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 131 - 131
  • [6] Improvement of cardiovascular risk factors by modified treatment in patients with metabolic syndrome
    Napalkov, DA
    Podzolkov, VI
    JOURNAL OF HYPERTENSION, 2004, 22 : S369 - S370
  • [7] Combination treatment and renal function in patients with chronic kidney disease
    Renke, Marcin
    Rutkowski, Przemyslaw
    Tylicki, Leszek
    Rutkowski, Boleslaw
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (02) : 146 - 147
  • [8] The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
    Rysz, Jacek
    Gluba-Brzozka, Anna
    Rysz-Gorzynska, Magdalena
    Franczyk, Beata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)
  • [9] Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome
    Satoh-Asahara, Noriko
    Suganami, Takayoshi
    Majima, Takafumi
    Kotani, Kazuhiko
    Kato, Yasuhisa
    Araki, Rika
    Koyama, Kazunori
    Okajima, Taiichiro
    Tanabe, Makito
    Oishi, Mariko
    Himeno, Akihiro
    Kono, Shigeo
    Sugawara, Akira
    Hattori, Masakazu
    Ogawa, Yoshihiro
    Shimatsu, Akira
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (02): : 265 - 273
  • [10] Chronic Kidney Disease, Metabolic Syndrome, and Cardiovascular Risk: Insights and Associated Mechanistic Pathways
    Nogueira, Thais Rodrigues
    Marreiros, Camila Santos
    de Almendra Freitas, Betania de Jesus e Silva
    CURRENT NUTRITION & FOOD SCIENCE, 2022, 18 (06) : 539 - 548
12345